Match!

Kinetic analysis of in vitro and in vivo release of prednisolone from the conjugate of glycol-chitosan and succinyl-prednisolone

Published on May 1, 2011in International Journal of Pharmaceutics4.213
· DOI :10.1016/j.ijpharm.2011.03.004
Hiraku Onishi24
Estimated H-index: 24
(Hoshi University),
Yuta Saito1
Estimated H-index: 1
(Hoshi University)
+ 1 AuthorsYoshiharu Machida38
Estimated H-index: 38
(Hoshi University)
Abstract
Recently, many people have developed rheumatoid arthritis (RA), and prednisolone (PD) is often used for treatment; however, long use and a large dose of PD can cause toxic side effects. In this study, in order to enhance the therapeutic effects and to suppress the toxic side effects, the conjugate (GC–SP) was prepared by coupling between glycol-chitosan (GC) and succinyl-prednisolone (SP). The drug-release properties of GC–SP were examined and analyzed kinetically. The plasma concentration–time profiles of GC–SP and released PD were investigated after i.v. injection to normal rats, and their pharmacokinetic profiles were analyzed. PD was stable and released gradually (ca. 1%/h) from GC–SP at physiological pH, while PD was unstable at basic pH and the release from GC–SP was accelerated at basic pH. GC–SP showed good systemic retention (more than 16-fold area under the plasma concentration–time curve (AUC) as compared to PD alone), and released PD gradually in vivo. The in vivo release rate was calculated to be much faster than the in vitro rate. From these results, it is expected that GC–SP will be accumulated at inflammatory sites based on enhanced permeability and retention (EPR) effects, and release PD there effectively.
  • References (23)
  • Citations (10)
📖 Papers frequently viewed together
5 Authors (Haiyan Zhou, ..., Hiraku Onishi)
179 Citations
103 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References23
Newest
Glucocorticoids are used as anti-inflammatory agents and are associated with many side effects including hyperglycemia, hypertension, pancreatitis, peptic ulcer, and so on. Hyperglycemia is a common side effect, but ketoacidosis is observed rarely. We present a girl who developed diabetic ketoacidosis after the administration of methylprednisolone during the treatment of acute rheumatic fever. She did not have diabetes and was not obese. She developed ketoacidosis after glucocorticoid therapy. G...
16 CitationsSource
A glycinate derivative of α-methylprednisolone (MP) was prepared and conjugated to a linear cyclodextrin polymer (CDP) with a loading of 12.4% w/w. The polymer conjugate (CDP-MP) self-assembled into nanoparticles with a size of 27 nm. Release kinetics of MP from the polymer conjugate showed a half-life (t 1/2 ) of 50 h in phosphate buffer solution (PBS) and 19 h in human plasma. In vitro, the proliferation of human lymphocytes was suppressed to a similar extent but with a delayed effect when CDP...
48 CitationsSource
#1Xin Ming Liu (UNMC: University of Nebraska Medical Center)H-Index: 25
#2Ling Dong Quan (UNMC: University of Nebraska Medical Center)H-Index: 12
Last. Dong Wang (UNMC: University of Nebraska Medical Center)H-Index: 28
view all 7 authors...
Purpose To develop a pH-sensitive dexamethasone (Dex)-containing N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer conjugate with well-defined structure for the improved treatment of rheumatoid arthritis (RA).
63 CitationsSource
#1Yahya Aghighi (Tehran University of Medical Sciences)H-Index: 8
#2Lida Attarod (Tehran University of Medical Sciences)H-Index: 1
Last. Maryam Javanmard (UT: University of Tehran)H-Index: 1
view all 3 authors...
Pulse therapy is one of the most well-known methods used in the treatment of juvenile rheumatoid arthritis. This study assessed the outcome of methylprednisolone pulse therapy, its rate of efficacy, and its associated complications in patients with juvenile rheumatoid arthritis (JRA). This cross-sectional study was performed on 120 children with JRA who attended the Pediatric Ward of Imam Khomeini Hospital from 1994 to 2004 and who had undergone around 500 cycles of methylprednisolone pulse ther...
7 CitationsSource
2 Citations
#1Ying Chau (MIT: Massachusetts Institute of Technology)H-Index: 17
#2Robert F. Padera (Brigham and Women's Hospital)H-Index: 58
Last. Robert Langer (MIT: Massachusetts Institute of Technology)H-Index: 229
view all 4 authors...
We have designed a new dextran-peptide-methotrexate conjugate to achieve tumor-targeted delivery of chemotherapeutics. The dextran carrier was selected to allow passive targeting and enhanced permeation and retention (EPR). The peptide linker has also been optimized to allow drug release in the presence of matrix-metalloproteinase-2 (MMP-2) and matrix-metalloproteinase-9 (MMP-9), 2 important tumor-associated enzymes. The new conjugate was assessed for its in vivo antitumor efficacy and systemic ...
91 CitationsSource
21 CitationsSource
#1Megumu HigakiH-Index: 21
#2Tsutomu IshiharaH-Index: 26
Last. Yutaka MizushimaH-Index: 45
view all 5 authors...
Objective: To examine the therapeutic activity of hydrophilic glucocorticoid encapsulated in PLGA nanoparticles, which have shown slow release and are targeted to inflamed joints after intravenous administration, in experimental arthritis models. Methods: Betamethasone sodium phosphate (BSP) encapsulated in PLGA nanoparticles with a size of 100–200 nm (PLGA-nanosteroid) was prepared using a modified oil in water emulsion solvent diffusion method with Zn ions and coated with lecithin. Rats with a...
86 CitationsSource
#1Kenichi Ito (Kyushu University)H-Index: 2
#2Mieko Inuo-Nakayama (Kyushu University)H-Index: 1
Last. HajimeNawata (Kyushu University)H-Index: 65
view all 11 authors...
4 CitationsSource
#1David CzockH-Index: 18
#2Frieder KellerH-Index: 31
Last. Ulla HäusslerH-Index: 3
view all 4 authors...
Glucocorticoids have pleiotropic effects that are used to treat diverse diseases such as asthma, rheumatoid arthritis, systemic lupus erythematosus and acute kidney transplant rejection. The most commonly used systemic glucocorticoids are hydrocortisone, prednisolone, methylprednisolone and dexamethasone. These glucocorticoids have good oral bioavailability and are eliminated mainly by hepatic metabolism and renal excretion of the metabolites. Plasma concentrations follow a biexponential pattern...
437 CitationsSource
Cited By10
Newest
A novel anionic nanogel system was prepared using succinylated glycol chitosan-succinyl prednisolone conjugate (S-GCh-SP). The nanogel, named NG(S), was evaluated in vitro and in vivo. S-GCh-SP formed a nanogel via the aggregation of hydrophobic prednisolone (PD) moieties and the introduced succinyl groups contributed to the negative surface charge of the nanogel. The resultant NG(S) had a PD content of 13.7% (w/w), was ca. 400 nm in size and had a ζ-potential of −28 mV. NG(S) released PD very s...
Source
#1Eva KoziolováH-Index: 7
Last. Tomáš EtrychH-Index: 33
view all 3 authors...
2 CitationsSource
#1Ryo Tabuchi (Sojo University)H-Index: 4
#2Makoto Anraku (Sojo University)H-Index: 24
Last. Fumitoshihirayama (Sojo University)H-Index: 42
view all 11 authors...
Abstract Surface-deacetylated chitin nanofibers (SDACNFs) reinforced with a sulfobutyl ether β-cyclodextrin (SBE-β-CD) (NFs-CDs) gel were developed to obtain a controlled release carrier of prednisolone (PD) for the treatment of colitis. PD was released slowly from the gel at both pH 1.2 and 6.8. The in vitro slow release of PD from the NFs-CDs gel was reflected in the in vivo absorption of the drug after oral administration to rats. These results suggest that a simple gel composed of a mixture ...
5 CitationsSource
#1Chunhong Li (Sichuan University)H-Index: 2
#2Hanmei Li (Sichuan University)H-Index: 9
Last. Xun Sun (Sichuan University)H-Index: 32
view all 8 authors...
Abstract Effective treatment for rheumatoid arthritis is hindered by the lack of drugs that selectively target inflamed joints. Liposomes, nanoparticles and conventional micelles loaded with limited amounts of drugs may be unstable in the circulation and result in uncontrolled drug release kinetics. Here we developed a new drug delivery system of pH-sensitive polymeric micelles based on an acid-labile hydrazone bond. Amphiphilic conjugates of a PEG-based derivative and the hydrophobic drug predn...
21 CitationsSource
#1Orathai Inta (Kasetsart University)H-Index: 1
#2Rangrong Yoksan (Kasetsart University)H-Index: 19
Last. Jumras Limtrakul (Kasetsart University)H-Index: 39
view all 3 authors...
Abstract The objective of the present research was to improve the hydrophobicity of chitosan, while retaining its antibacterial activity, through the grafting of dodecenyl succinyl chains onto phthaloyl chitosan, mainly at the C-6 position. Dodecenyl succinylated phthaloyl chitosan (DS-g-PHCTS) was synthesized via phthaloylation–dodecenyl succinylation–hydrazinolysis. The obtained derivatives were characterized by FTIR, 1H NMR and XRD. Hydrazinolysis time was found to be a key factor in controll...
23 CitationsSource
#1Youyu LiuH-Index: 3
#2Kun YanH-Index: 6
Last. Xiaowen ShiH-Index: 29
view all 6 authors...
Electrical signal guided drug release from conductive surface provides a simple and straightforward way for advanced drug delivery. In this study, we investigated the ibuprofen release from electrodeposited chitosan hydrogel by applying electrical signals. Specifically, chitosan hydrogel was electrodeposited on titanium plate and used as a matrix for ibuprofen load and release. The release of ibuprofen from the chitosan hydrogel on titanium plate was pH sensitive. By applying a positive or negat...
4 CitationsSource
Aims: to enhance the anti-inflammatory effect as well as oral absorption of prednisolone (PR), through formulation of colonic targeted microspheres prepared from a blend of time and pHdependent polymers and loaded with PR. Study Design: In Vitro and In Vivo Evaluation of Combined Time and pHDependent Oral Colonic Targeted Prednisolone Microspheres. Place and Duration of Study: Department of Pharmaceutics and Industrial Pharmacy, Helwan University, Cairo, Egypt between June 2011 and October 2012....
1 CitationsSource
#1Fang Yuan (UNMC: University of Nebraska Medical Center)H-Index: 5
#2Ling Dong Quan (UNMC: University of Nebraska Medical Center)H-Index: 12
Last. Dong Wang (UNMC: University of Nebraska Medical Center)H-Index: 28
view all 5 authors...
Rheumatoid arthritis (RA) is a chronic autoimmune disease that is considered to be one of the major public health problems worldwide. The development of therapies that target tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and co-stimulatory pathways that regulate the immune system have revolutionized the care of patients with RA. Despite these advances, many patients continue to experience symptomatic and functional impairment. To address this issue, more recent therapies that have been d...
61 CitationsSource
#1A. S. BerezinH-Index: 2
#2E. A. LomkovaH-Index: 1
Last. Yu. A. SkorikH-Index: 4
view all 3 authors...
This review summarizes the current research on the development of biologically active polymer compounds based on chitosan and its derivatives; it systematizes approaches taken for the design of conjugates based on a given polymer, and it covers the latest trends in the development of targeted drug delivery systems. An analysis of published data shows that the conjugation of biologically active substances with chitosan and its derivatives results in promising materials for use as drug delivery sy...
21 CitationsSource